17 employees
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
2020
$24M
from 6 investors over 6 rounds
Anavo Therapeutics BV raised $9.3M on May 2, 2023
Investors: Inkef, M Ventures and Bioqube Ventures
Anavo Therapeutics BV raised $24M on April 22, 2021
Investors: Bioqube Ventures, Inkef and M Ventures